2009
DOI: 10.1016/j.biomaterials.2009.01.014
|View full text |Cite
|
Sign up to set email alerts
|

Multiscale requirements for bioencapsulation in medicine and biotechnology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
133
0
2

Year Published

2011
2011
2020
2020

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 184 publications
(143 citation statements)
references
References 154 publications
3
133
0
2
Order By: Relevance
“…The development of encapsulation techniques, including the PEC capsules, has progressed towards a precise and targeted characterisation of the morphology, physicochemical properties of capsules, biocompatibility and their changes over time, using the latest techniques [11,12] for applications in biotechnology and medicine. Additionally, there is also an increased effort to optimise immobilization by predicting and modelling the bioengineering parameters of potential industrial processes [13].…”
Section: Introductionmentioning
confidence: 99%
“…The development of encapsulation techniques, including the PEC capsules, has progressed towards a precise and targeted characterisation of the morphology, physicochemical properties of capsules, biocompatibility and their changes over time, using the latest techniques [11,12] for applications in biotechnology and medicine. Additionally, there is also an increased effort to optimise immobilization by predicting and modelling the bioengineering parameters of potential industrial processes [13].…”
Section: Introductionmentioning
confidence: 99%
“…Isolated islets can be encapsulated within permeable hydrogels such as alginate to provide an immunoprotective barrier that may preclude pharmacological immunosuppression. 8,9 However, encapsulation devices introduce a transport barrier between the host and graft tissues and inherently limit oxygen supply, compromising graft function and cell viability, 10 problems that scale with device wall thickness. 11,12 Typically grafts are implanted in subcutaneous 13 or intraperitoneal 14 sites where partial pressures of oxygen (pO 2 ) are approximately 60 and 40 mm Hg, respectively, which is lower than that of arterial blood (>80 mm Hg).…”
Section: Introductionmentioning
confidence: 99%
“…In order to protect grafts against this reactivity, encapsulation methods have been developed for implants in extra-hepatic sites [5,6]. Alginate microcapsules have been the longest in use and technical advances have been made in improving their biocompatibility, stability and permeability, and in producing variants with selected properties [7][8][9]. They have allowed successful allotransplants of islet tissue in the peritoneal cavity of rodents [10][11][12] and of large animals [13,14], often without the need for continuous immune suppression [11][12][13][14].…”
Section: Introductionmentioning
confidence: 99%